Efficacy of isCGM on HbA1c improvement and behavior in Japanese type 2 diabetic patient

Not Applicable

• Conditions: Type 2 Diabetes Mellitus

• Registration Number: JPRN-UMIN000043563
• Lead Sponsor: Tokyo Teishin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-10
• Study Completion: 2021-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

1)Contraindication of Freestyle Libre on the attachment document 2)Patients with an HbA1c level of less than 7.0% (20 to 65 years old) and patients with an HbA1c level of less than 7.5% (65 to 75 years old) 3)Mentally handicapped patient unsuitable for study evaluation 4)Pregnant women 5)Poor prognostic patient with malignancy 6)Patient with progressive diabetic retinopathy 7)Less than eGFR 30 ml/min/1.73m2 8)Hemoglobinopathy 9)Exercise restricted patient 10)Patient in treatment with drugs affect blood glucose levels including steroids, anti-cancer drugs, interferon et al 11)Dementia 12)Patients with therapeutic contraindications to the use of Freestyle Libre 13)Patients deemed unsuitable for this study by the researcher in this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified